Carregant...

Increasing Incidence of Brain Metastasis in Patients with Advanced Hepatocellular Carcinoma in the Era of Antiangiogenic Targeted Therapy

AIM. Brain metastasis was regarded, until recently, as a rare and late-stage event in patients with hepatocellular carcinoma (HCC). With the prolongation of survival in patients with advanced HCC by molecular targeted agents, this may have changed. We aimed to examine whether or not the incidence of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shao, Yu-Yun, Lu, Li-Chun, Cheng, Ann-Lii, Hsu, Chih-Hung
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228055/
https://ncbi.nlm.nih.gov/pubmed/21212425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0272
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!